Prevalence Survey of Plasmodium Falciparum Antimalarial Drug Resistance Markers

NCT02895568 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 399

Last updated 2022-04-07

No results posted yet for this study

Summary

This study is to measure prevalence of established and candidate molecular markers of drug resistant malaria at Komé, Doba, Republic of Chad.

Conditions

  • Plasmodium Falciparum

Sponsors & Collaborators

  • Worldwide Antimalarial Resistance Network

    collaborator NETWORK
  • Mahidol University

    collaborator OTHER
  • University of Oxford

    lead OTHER

Eligibility

Min Age
6 Months
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-16
Primary Completion
2018-09-06
Completion
2018-09-06

Countries

  • Chad

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02895568 on ClinicalTrials.gov